CRAB TRIAL: UPDATED RESULTS FROM A PROSPECTIVE PHASE II STUDY EVALUATING NEOADJUVANT CAPECITABINE, RADIOTHERAPY (RT) AND BEVACIZUMAB IN LOCALLY ADVANCED RECTAL CANCER

被引：0

作者：

Velenik, V. ^{[1
]}

Ocvirk, J. ^{[2
]}

Omejc, M. ^{[3
]}

Music, M. ^{[1
]}

Bracko, M. ^{[1
]}

Anderluh, F. ^{[1
]}

Oblak, I. ^{[1
]}

Edhemovic, I. ^{[1
]}

Brecelj, E. ^{[1
]}

Kropivnik, M. ^{[1
]}

机构：

[1] Inst Oncol, Ljubljana, Slovenia

[2] Oncol Inst Ljubljana, Ljubljana, Slovenia

[3] Univ Med Ctr, Ljubljana, Slovenia

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：210 / 211

页数：2

共 50 条

[1] Neoadjuvant bevacizumab, capecitabine, and radiotherapy in locally advanced rectal cancer: Interim results of a phase II CRAB trial.
Velenik, V.
Ocvirk, J.
Omejc, M.
Music, M.
Anderluh, F.
Oblak, I.
Edhemovic, I.
Bracelj, E.
Kropivnik, M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[2] Long term efficacy results from the phase II CRAB trial: Neoadjuvant bevacizumab, capecitabine and radiotherapy in locally advanced rectal cancer
Velenik, V.
Omejc, M.
Ocvirk, J.
Edhemovic, I.
Anderluh, F.
Oblak, I.
But-Hadzic, J.
[J]. ANNALS OF ONCOLOGY, 2018, 29
[3] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
Crane, Christopher H.
Eng, Cathy
Feig, Barry W.
Das, Prajnan
Skibber, John M.
Chang, George J.
Wolff, Robert A.
Krishnan, Sunil
Hamilton, Stanley
Janjan, Nora A.
Maru, Dipen M.
Ellis, Lee M.
Rodriguez-Bigas, Miguel A.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
[4] Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
Velenik, Vaneja
Ocvirk, Janja
Music, Maja
Bracko, Matej
Anderluh, Franc
Oblak, Irena
Edhemovic, Ibrahim
Brecelj, Erik
Kropivnik, Mateja
Omejc, Mirko
[J]. RADIATION ONCOLOGY, 2011, 6
[5] Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
Vaneja Velenik
Janja Ocvirk
Maja Music
Matej Bracko
Franc Anderluh
Irena Oblak
Ibrahim Edhemovic
Erik Brecelj
Mateja Kropivnik
Mirko Omejc
[J]. Radiation Oncology, 6
[6] CRAB trial: Long-term results from a prospective phase II study evaluating neoadjuvant capecitabine, radiotherapy (RI) and revacizumab in locally advanced rectal cancer
Velenik, V.
Ocvirk, J.
Music, M.
Bracko, M.
Anderluh, F.
Oblak, I.
Edhemovic, I.
Brecelj, E.
Kropivnik, M.
Omejc, M.
[J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S506 - S506
[7] Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer: results of a phase II trial
Velenik, V.
Ocvirk, J.
Oblak, I.
Anderluh, F.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[8] PROSPECTIVE TRIAL OF SYNCHRONOUS CAPECITABINE, RADIOTHERAPY AND BEVACIZUMAB FOR LOCALLY ADVANCED RECTAL CANCER (CRAB)
Velenik, Vaneja
Ocvirk, Janja
Music, Maja
Matej, Bracko
Anderluh, Franc
Oblak, Irena
Edhemovic, Ibrahim
Brecelj, Erik
Kropivnik, Mateja
Omejc, Mirko
[J]. ANNALS OF ONCOLOGY, 2012, 23 : 113 - 113
[9] RESULTS FROM THE PHASE II XERT STUDY: NEOADJUVANT CETUXIMAB, CAPECITABINE, AND RADIOTHERAPY (RT) IN LOCALLY ADVANCED RESECTABLE RECTAL CANCER
Velenik, V.
Ocvirk, J.
Oblak, I
Anderluh, F.
[J]. ANNALS OF ONCOLOGY, 2009, 20 : 109 - 109
[10] Phase II trial of neoadjuvant bevacizumab (BEV), capecitabine (CAP), and radiotherapy (XRT) for locally advanced rectal cancer
Crane, C. H.
Eng, C.
Feig, B. W.
Das, P.
Skibber, J. M.
Chang, G. J.
Wolff, R. A.
Krishnan, S.
Maru, D. M.
Ellis, L. M.
Rodriguez-Bigas, M. A.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →